EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Effect of mannitol‐based reduced‐volume hydration on kidney function in concomitant cisplatin‐based chemoradiation for head‐and‐neck squamous cell carcinoma

Christopher Paschen iD, Matthias Moll, Gabriela Altorjai, Manfred Hecking, Thorsten Fuereder, Joachim Widder, Harald Herrmann

Head & Neck · 2023

DOI: 10.1002/hed.27438 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Head & Neck, 2023. Verfasst von Christopher Paschen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, Vienna, Austria. Hauptthemen laut MEDLINE: Antineoplastic Agents, Head and Neck Neoplasms, Acute Kidney Injury. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Nephrotoxicity is frequent in cisplatin‐based chemoradiation of head and neck squamous cell carcinoma (HNSCC). Toxicity outcomes and achieved cisplatin‐doses after change of departmental hydration policy are presented.

Methods

We performed a retrospective time‐series analysis of HNSCC patients undergoing chemoradiation with conventional hydration (CH) between 01/2017 and 09/2018 versus shorter hydration with mannitol (SHM) between 09/2018 and 08/2019 to compare the rate of acute kidney injury (AKI) and cumulative cisplatin dose.

Results

Among 113 HNSCC patients, SHM ( n = 35) in comparison to CH ( n = 78) correlated with less AKI (54.3% vs. 74.4%; p = 0.034) and higher cisplatin doses (82.9% vs. 61.5% ≥200 mg/m 2 ; p = 0.025). AKI ≥grade 2 was lower with SHM (2.9% vs. CH: 22.8%; p = 0.01). AKI occurred more frequently in females (92.6% vs. males: 60.5%, p = 0.002). Females received lower cumulative cisplatin doses (51.9% vs. males: 73.3%; p = 0.037).

Conclusions

We observed less AKI and higher cumulative chemotherapy doses with SHM. Female patients were at higher risk of AKI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsHead and Neck NeoplasmsAcute Kidney InjuryMaleHumansFemaleCisplatinSquamous Cell Carcinoma of Head and NeckMannitolRetrospective StudiesKidney

Stichwörter der Autor:innen

HNSCCcisplatinmannitolnephrotoxicityshort hydration

Substanzen

CisplatinMannitolAntineoplastic Agents

Autor:innen und Institutionen

  • Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, Vienna, Austria.
  • Department of Radiation Oncology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Division of Oncology, Department of Medicine I, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.

ORCID-Profile: Christopher Paschen

Zitieren

APA

Paschen, C., Moll, M., Altorjai, G., Hecking, M., Fuereder, T., Widder, J., & Herrmann, H. (2023). Effect of mannitol‐based reduced‐volume hydration on kidney function in concomitant cisplatin‐based chemoradiation for head‐and‐neck squamous cell carcinoma. Head & Neck. https://doi.org/10.1002/hed.27438

Vancouver

Paschen C, Moll M, Altorjai G, Hecking M, Fuereder T, Widder J, et al. Effect of mannitol‐based reduced‐volume hydration on kidney function in concomitant cisplatin‐based chemoradiation for head‐and‐neck squamous cell carcinoma. Head & Neck. 2023. doi:10.1002/hed.27438

BibTeX
@article{Paschen2023,
  author = {Paschen, Christopher and Moll, Matthias and Altorjai, Gabriela and Hecking, Manfred and Fuereder, Thorsten and Widder, Joachim and Herrmann, Harald},
  title = {Effect of mannitol‐based reduced‐volume hydration on kidney function in concomitant cisplatin‐based chemoradiation for head‐and‐neck squamous cell carcinoma},
  journal = {Head & Neck},
  year = {2023},
  doi = {10.1002/hed.27438}
}
Kostenlos starten →